Pulmonary vascular and cardiac effects of peroxynitrite decomposition in newborn rats

Free Radical Biology and Medicine

Volumn 49, Issue 8, 2010, Pages 1306-1314

  Belik, Jaques ^a,b,c   Stevens, Danielle ^d   Pan, Jingyi ^a   McIntyre, Brendan A S ^a   Kantores, Crystal ^b   Ivanovska, Julijana ^c   Xu, Emily Z ^b   Ibrahim, Christine ^c   Panama, Brian K ^c   Backx, Peter H ^c   McNamara, Patrick J ^a,b,c   Jankov, Robert P ^b,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiomyocyte; Echocardiography; Free radicals; Neonate; Nitrate; Smooth muscle

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 NITROTYROSINE; 5,10,15,20 TETRAKIS(4 SULFONATOPHENYL)PORPHYRINATO IRON(III); ACETYLCHOLINE; GUANYLATE CYCLASE INHIBITOR; IRON DERIVATIVE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIAL WALL THICKNESS; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY MUSCLE; ARTERY WALL; ARTICLE; BODY WEIGHT; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; HEART MUSCLE CELL; HEART VENTRICLE; HEART VENTRICLE EJECTION; HEART VENTRICLE SEPTUM; HEART WEIGHT; HEMODYNAMICS; HYPOXIA; IN VITRO STUDY; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE FIBER; VASODILATATION;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; CARDIOMEGALY; CATALYSIS; CELL GROWTH PROCESSES; CELLS, CULTURED; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; HYPERTENSION, PULMONARY; LUNG; METALLOPORPHYRINS; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; PEROXYNITROUS ACID; PULMONARY ARTERY; RATS;

ANIMALIA; RATTUS;

EID: 79957721052     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.07.021     Document Type: Article

References (26)

1. O'Donnell V.B., Freeman B.A. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ. Res. 2001, 88:12-21.
2. Jankov R.P., Kantores C., Pan J., Belik J. Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L233-L245.
3. Lakshminrusimha S., Russell J.A., Wedgwood S., Gugino S.F., Kazzaz J.A., Davis J.M., et al. Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2006, 174:1370-1377.
4. Belik J., Jankov R.P., Pan J., Tanswell A.K. Peroxynitrite inhibits relaxation and induces pulmonary artery muscle contraction in the newborn rat. Free Radic. Biol. Med. 2004, 37:1384-1392.
5. 2. Am. J. Physiol. 1999, 277:H978-H985.
6. Chabot F., Mitchell J.A., Quinlan G.J., Evans T.W. Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: role of poly (adenosine 5'-diphosphoribose) synthase. Br. J. Pharmacol. 1997, 121:485-490.
7. Genovese T., Mazzon E., Esposito E., Muia C., Di P.R., Bramanti P., et al. Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury. Free Radic. Biol. Med. 2007, 43:763-780.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
9. + channel gene expression in rat ventricle. J. Physiol. 1997, 504(Pt 2):271-286.
10. Le Cras T.D., Markham N.E., Tuder R.M., Voelkel N.F., Abman S.H. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L555-L562.
11. Sohn S., Kim H.S., Han J.J. Doppler flow velocity measurement to assess changes in inotropy and afterload: a study in healthy dogs. Echocardiography 2002, 19:207-213.
12. Turan N.N., Yildiz G., Gumusel B., Demiryurek A.T. Ischemic and peroxynitrite preconditioning effects in chronic hypoxic rat lung. Exp. Lung Res. 2008, 34:325-341.
13. Misko T.P., Highkin M.K., Veenhuizen A.W., Manning P.T., Stern M.K., Currie M.G., et al. Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 1998, 273:15646-15653.
14. Kagota S., Tada Y., Nejime N., Nakamura K., Kunitomo M., Shinozuka K. Chronic production of peroxynitrite in the vascular wall impairs vasorelaxation function in SHR/NDmcr-cp rats, an animal model of metabolic syndrome. J. Pharmacol. Sci. 2009, 109:556-564.
15. Sugiura H., Liu X., Kobayashi T., Togo S., Ertl R.F., Kawasaki S., et al. Reactive nitrogen species augment fibroblast-mediated collagen gel contraction, mediator production, and chemotaxis. Am. J. Respir. Cell Mol. Biol. 2006, 34:592-599.
16. DeMarco V.G., Habibi J., Whaley-Connell A.T., Schneider R.I., Sowers J.R., Andresen B.T., et al. Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1128-H1139.
17. Ichikawa T., Sugiura H., Koarai A., Yanagisawa S., Kanda M., Hayata A., et al. Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L800-L808.
18. Kleschyov A.L., Oelze M., Daiber A., Huang Y., Mollnau H., Schulz E., et al. Does nitric oxide mediate the vasodilator activity of nitroglycerin?. Circ. Res. 2003, 93:e104-e112.
19. Tseng C.M., Tabrizi-Fard M.A., Fung H.L. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation. J. Pharmacol. Exp. Ther. 2000, 292:737-742.
20. Teixeira C.E., Priviero F.B., Todd J., Webb R.C. Vasorelaxing effect of BAY 41-2272 in rat basilar artery: involvement of cGMP-dependent and independent mechanisms. Hypertension 2006, 47:596-602.
21. Mulsch A., Oelze M., Kloss S., Mollnau H., Topfer A., Smolenski A., et al. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation 2001, 103:2188-2194.
22. Oelze M., Mollnau H., Hoffmann N., Warnholtz A., Bodenschatz M., Smolenski A., et al. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ. Res. 2000, 87:999-1005.
23. Weisbrod R.M., Griswold M.C., Yaghoubi M., Komalavilas P., Lincoln T.M., Cohen R.A. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide. Br. J. Pharmacol. 1998, 125:1695-1707.
24. Klassen S.S., Rabkin S.W. The metalloporphyrin FeTPPS but not by cyclosporin A antagonizes the interaction of peroxynitrate and hydrogen peroxide on cardiomyocyte cell death. Naunyn Schmiedebergs Arch. Pharmacol. 2009, 379:149-161.
25. Lauzier B., Sicard P., Bouchot O., Delemasure S., Moreau D., Vergely C., et al. A peroxynitrite decomposition catalyst: FeTPPS confers cardioprotection during reperfusion after cardioplegic arrest in a working isolated rat heart model. Fundam. Clin. Pharmacol. 2007, 21:173-180.
26. Jankov R.P., Negus A., Tanswell A.K. Antioxidants as therapy in the newborn: some words of caution. Pediatr. Res. 2001, 50:681-687.